Andrews Nancy C has filed 7 insider transactions across 2 companies since May 2023.
Most recent transaction: a grant/award of 18000 shares of Maze Therapeutics, Inc. ($MAZE) on September 22, 2025.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sept. 22, 2025 | Maze Therapeutics, Inc. | $MAZE | Andrews Nancy C | Not found | A | Stock Option (Right to Buy) | 18000 | $0.00 | 18,000.0000 | 0 | 9999.99% | 0.00% |
| May 21, 2025 | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. | $CRL | Andrews Nancy C | Director | A | Common Stock | 946 | $134.98 | 3,964.0000 | 51,201,000 | 31.35% | 0.00% |
| May 21, 2025 | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. | $CRL | Andrews Nancy C | Director | A | Stock Options (Right to Buy) | 2076 | $134.98 | 2,076.0000 | 51,201,000 | 9999.99% | 0.00% |
| May 13, 2024 | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. | $CRL | Andrews Nancy C | Director | A | Stock Options (Right to Buy) | 1311 | $228.41 | 1,311.0000 | 51,552,000 | 9999.99% | 0.00% |
| May 13, 2024 | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. | $CRL | Andrews Nancy C | Director | A | Common Stock | 559 | $228.41 | 3,018.0000 | 51,552,000 | 22.73% | 0.00% |
| May 15, 2023 | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. | $CRL | Andrews Nancy C | Director | A | Common Stock | 664 | $0.00 | 2,459.0000 | 50,944,000 | 36.99% | 0.00% |
| May 15, 2023 | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. | $CRL | Andrews Nancy C | Director | A | Stock Options (Right to Buy) | 1669 | $192.36 | 1,669.0000 | 50,944,000 | 9999.99% | 0.00% |